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ABSTRACT
Objective: This communication explores a lead fraction from methanolic extract of novel Stevia species raised under in vitro conditions for its various 
biological activities.
Methods: The dried Stevia leaves were crushed in methanol to get the polar extract. This methanol extract was tested for pancreatic lipase and 
alpha-amylase inhibitory activity using quantitative plate assays. Antibacterial property of the extract was also evaluated against Staphylococcus 
epidermidis, Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudomonas aeruginosa. Further, the antioxidant potential was evaluated 
using 1,1-diphenyl-2-picrylhydrazyl.
Results: The methanolic extract inhibited pancreatic lipase with IC50 of 5.74 µg/ml in a similar manner to a well-known anti-obesity drug in the 
market orlistat. The methanolic extract also showed a better pancreatic α-amylase inhibitory activity (IC50=88 µg/ml) than acarbose. Further, the 
lead fraction exhibited 88.48% antioxidant activity. It also exhibited broad spectrum antimicrobial activity against the spectrum of Gram-positive and 
Gram-negative bacteria tested under laboratory conditions with a minimal inhibitory concentration ranging from 1.95 to 31.25 µg/ml.
Conclusion: Thus, this study signifies the vast potential of the lead fraction from a novel Stevia species for further development into a herbal 
formulation for prevention of various infectious and non-infectious diseases.
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INTRODUCTION
Obesity is a daunting health problem which occurs due to an imbalance 
between calorie uptake and utilization. Today obesity is becoming the 
major cause of preventable deaths, both in developed and developing 
nations [1]. It has been reported by World Health Organization (WHO) 
that every third individual around the globe is obese. It was previously 
known as disorder but recently WHO has declared it as a disease [2]. 
Pancreatic lipase is the major contributing enzyme that starts lipid 
metabolism by acting on triacylglycerides and resulting in the formation 
of monomers that are absorbed and accumulated in the body resulting 
to obesity. As action of pancreatic lipase is inhibited, most of the 
triacylglycerides are not converted to their simpler forms and hence are 
excreted out of the body [3]. Further, the most common disease related 
to obesity is Type 2 diabetes. Obesity and diabetes are two interlinked 
global health problems. Degradation of starch into sugars by α-amylase 
leads to increased postprandial hyperglycemia. Hence, inhibiting the 
action of α-amylase is the best way to control diabetes [4]. The current 
armamentarium of drugs available for the treatment of obesity suffers 
from various unwanted effects including fecal urgency, oily stools, 
abdominal cramps, flatulence, and oozing of oil from the anus leading 
to oily spotting [1]. Thus, there is an utmost requirement for exploring 
alternate avenues for development of new drugs for the treatment of 
these diseases with less or no side effects. Presently, there has been a 
lot of emphases given on the development of novel drugs from natural 
products due to their lesser antigenicity [5].
Stevia, commonly known as honey leaf or sweet leaf plant is a small 
perennial herb of South American origin belonging to the Asteraceae 
family [6]. Recent scientific trails have shown that leaves of Stevia 
possess broad spectrum antimicrobial, antiviral, and antifungal 
properties [7,8]. Further, the leaves of the plant also possess 
antihypertensive [9], antihyperglycemic [10], antitumor [7], and 
immunomodulatory effects [11]. Recently, Stevia grown under 
laboratory condition exhibited the presence of steviosides such as 
glycosides, steviosides, and rebaudioside. The ethanolic extract of these 
plants exhibited various medicinal properties including antioxidant 
and antimicrobial property [12]. Stevia plant contains a well-known 
non calorie natural sweetener stevioside [13]. Non calorie sweeteners 
are potential agents for obesity management [14] as they reduce the 
calorie intake of sugars. However, there exist very scanty reports on 
exploration of Stevia for anti-obesity properties. This is the first report 
of Stevia extract inhibiting pancreatic lipase with a potential similar to 
orlistat. Here in this study, we report the potential of a lead fraction 
obtained from a methanolic extract of in vitro raised Stevia plant for 
anti-obesity and antidiabetes, antioxidant, and antimicrobial activity 
leading to safer solution of obesity and diabetes management by a 
natural herbal agent with possible fewer side effects.
METHODS
Procurement of plant sample and preparation of lead fraction
In vitro raised novel Stevia strain was procured from GVS Biotech Pvt. 
Ltd., Punjab, India. The leaves of the Stevia plant were air dried at 37°C 
and crushed into a fine powder using pestle mortar. Further, 2 g of the 
powdered leaves was extracted using methanol (Merck GR, USA) over 
a rotatory shaker for 16-18 hrs at 130 rpm, 28±1°C. The solvent was 
filtered using Whatman filter Paper 1. The solvent was completely 
evaporated, and the leftover extract was reconstituted in dimethyl 
sulfoxide (DMSO) (Merck GR, USA). The crude extract was tested for its 
various biological activities.
Dose response activity of methanolic extract of Stevia against 
pancreatic lipase
In vitro pancreatic lipase inhibitory activity was evaluated using a slight 
modified protocol described by Gupta et al. [1]. Varying concentrations 
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of Stevia formulation ranging from 20 to 120 µg/ml were pre-incubated 
with 20 µl of porcine pancreatic lipase (40 U) at 37°C for 1 hr. Then, 
100 µl of p-nitrophenyl laurate (PNPL) (2 mM) was added to start the 
reaction. The volume was made up to 250 µl using Tris buffer (pH 7.4). 
The plate was then subsequently incubated at 37°C for 3 hrs. The 
reading of the 96-well plate was measured at 410 nm using a 96-well 
plate reader. Orlistat was used as a positive control whereas negative 
control only comprised enzyme and PNPL.
In vitro pancreatic amylase inhibition assay
Inhibition of pancreatic amylase by Stevia formulation was done 
according to modified protocol [15]. All the concentrations were 
reduced to 300 µl, and the test was performed in 96-well plate. In this 
assay, acarbose served as positive control.
In vitro assay for anti-oxidant activity
The free radical scavenging property of methanolic extract of Stevia 
was determined by recording the change in the optical density 
of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals (DPPH, 
Sigma-Aldrich, USA). Briefly, to 1 ml of DPPH (100 uM), 50 µl of 
extract (1 mg/ml) was added and incubated at 37°C for half an hour. 
Further, the absorbance was recorded at wavelength 517 nm using 
a ultraviolet-visible (UV-visible) spectrophotometer (Hitachi 
U-2900, Japan). Both positive (gallic acid) and negative (DMSO) controls 
were used in assay [16].
Free radical scavenging activity was calculated as:
% Free radical scavenging=







Total phenolic content of methanol extract
Total phenol content of the mixture was estimated using Folin–Ciocalteu 
reagent based assay using gallic acid as standard. The methanolic 
extract (1 mg/ml) was mixed with 500 µl (HiMedia, Mumbai, India) of 
Folin–Ciocalteu reagent followed by addition of 1.5 ml of 2% sodium 
carbonate (HiMedia, Mumbai, India). The final volume was made to 
5 ml using double distilled water. This mixture was then subsequently 
incubated at 37°C for half an hour. Using a UV-visible spectrophotometer, 
the absorbance was measured at 765 nm. The total phenolic content 
was estimated from the regression equation: y=0.026x−0.008 with 
R2=0.99 [16].
In vitro broth dilution assay for minimal inhibitory concentration 
(MIC) estimation
In vitro broth dilution assay to estimate MIC of the extract was performed 
as per described by Gomber and Saxena [17]. Briefly describing, 125 µl 
of Mueller-Hinton broth was dispensed into each well. Subsequently, 
50 µl of 0.5 McFarland adjusted 18 hrs old test organisms were added 
into wells, and the plate was kept at 37°C for 2.5 hrs. Further, 25 µl 
of the test extract (i.e., two-fold serial dilutions of concentrations 
between 62.5 and 0.48 µg/ml) was dispensed into each well, and 
the plate was incubated at 37°C for 24 hrs. Further, 20 µl of 0.02% of 
3-(4,5-Dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide (MTT) 
was added, and the plate was again incubated at 37°C for 60 minutes. 
The change in color in the wells due to difference in antimicrobial 
activities from pink (live) to yellow (dead) was observed and MIC was 
calculated. All the tests were performed in triplicates.
RESULTS
Dose response activity of methanolic extract of Stevia against 
pancreatic lipase
The quantitative plate assay ascertained the reduced pancreatic lipase 
activity by the methanolic extract of novel Stevia sp. and the only lipase 
inhibitor orlistat. Stevia extract inhibited pancreatic lipase with an IC50 
of 2.7 µg/ml which was quite comparable to orlistat (IC50=5.7 µg/ml). 
The inhibition pattern of Stevia extract was also similar to orlistat 
(Fig. 1).
In vitro pancreatic α-amylase inhibitory activity of methanolic 
extract of Stevia
This study showed the greater potential of Stevia species for inhibition 
of pancreatic amylase. The IC50 value of the methanolic extract was 
found to be 88 µg/ml as compared to that acarbose (IC50=91.1 µg/ml) 
(Fig. 2).
In vitro assay for antioxidant activity of methanolic extract of Stevia
The methanolic extract of Stevia in the DPPH assay exhibited 
87.48±2.08% antioxidant activity which was better than as compared 
to standard gallic acid which showed 84.16±1.49% antioxidant activity. 
There was a noticeable change in color from purple to yellow following 
scavenging reaction. Further, the total phenolic content of the lead 
fraction amounts to 21.42 µg/ml.
In vitro broth dilution assay for MIC estimation
The methanolic extract of in vitro raised Stevia exhibited better MIC 
value (1.95-3.91 µg/ml) for Staphylococcus epidermidis, Escherichia 
coli, and Bacillus subtilis whereas it showed higher MIC values (15.625-
31.25 µg/ml) for Staphylococcus aureus and Pseudomonas aeruginosa 
when compared to streptomycin under in vitro conditions (Table 1).
DISCUSSION
Stevia is a safe, calorie-free, and natural sweetener with no side effects 
and it is also considered as a potential antidiabetic supplement also 
Fig. 1: Dose-response curves for inhibition of pancreatic lipase by 
Stevia formulation. Orlistat served as positive control
Fig. 2: Dose-response curve for inhibition of α-amylase by Stevia 
extract. Acarbose served as positive control
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possessing antioxidant and antimicrobial properties [18,19]. There are 
over 240 species of Stevia, and they have been largely focussed on their 
sweetening properties and in the development antidiabetic agent [20]. 
Apart from this, several studies have been carried which determined 
in vitro antimicrobial, anticancer, antioxidant, and anticancer properties 
of the Stevia plant [6]. However, very few or almost no efforts have 
been made to explore the lipase inhibitory (anti-obesity) activity and 
correlate it with the antidiabetic property of the plant. There exists 
only one report regarding pancreatic lipase inhibitory activity of Stevia 
rebaudiana [21]. Since obesity and diabetes are interrelated; this would 
be a novel avenue for management of two of the most threatening 
disease of the modern world. In this context, we chose to evaluate 
both the anti-obesity and antidiabetic property of the in vitro raised 
Stevia plant. The study was focussed on inhibition of two enzymes, 
viz., pancreatic lipase and α-amylase for anti-obesity and antidiabetic 
property, respectively [1,4]. The lipase inhibitory property of the 
methanolic extract of in vitro raised Stevia plant (IC50=5.74 µg/ml) in 
this study was found to be much better than that observed in Stevia 
(IC50=530 µg/ml) [21]. Pancreatic lipase inhibitory potential of the lead 
fraction was better than hesperidin and carnosic acid isolated from 
citrus fruits and Salvia officinalis, respectively [22,23]. It is believed 
that further purification of the methanolic fraction will increase the 
inhibition response, which would further able to demonstrate exact IC50 
of the purified compound [1]. Similar pattern was observed in several 
microbial lipase inhibitors such as vibralactone and Percy Quin whose 
phospholipids inhibitory efficiency increased on purification [24,25].
Alpha-amylase is a key enzyme which is accountable for degradation 
of starch into monosaccharides. Alpha-amylase hydrolyses complex 
sugar molecules into simpler sugars that are absorbed by the villi of 
small intestine, hence passing into the hepatic portal vein. These 
sugars are responsible for increase in postprandial glucose levels. The 
inhibitors of alpha-amylase have been given another name as starch 
blockers because they prevent absorption of dietary starch in the body 
ultimately lowering postprandial glucose levels [26]. The lead fraction 
in this study also exhibited comparable α-amylase inhibitory activity. 
In this study, the α-amylase inhibitory activity (IC50=88 µg/ml) was 
found to be far better than aqueous extracts of S. rebaudiana reported 
by Ruiz-Ruiz et al. [15] and Patil et al. [27]. The extract might exhibit 
amylase inhibitory activity by binding at substrate binding site/active 
site of alpha-amylase, an enzyme responsible for the breakdown of 
α-1,4 glycosidic bonds in starch and other polysaccharides that increase 
the sugar level in body and subsequently leading to postprandial 
hyperglycemia. Therefore, this report supports the theory that moieties 
from medicinal plants having a potential to inhibit α-amylase can be 
used as a pharmacophore for managing postprandial hyperglycemia 
with minimal side effects [15].
Calculation of MIC using MTT is a widely known precise technique to 
estimate the response of a microorganism to a specific antibiotic [28]. 
This study reports the potential of methanolic fraction of Stevia 
plant to inhibit S. epidermidis, E. coli, and B. subtilis with a lower 
MIC value (1.95-3.91 µg/ml) whereas it displayed higher MIC value 
(15.62-31.25 µg/ml) for S. aureus and P. aeruginosa when compared to 
streptomycin. The antibacterial property reported in this study is far 
better than the earlier studies reporting MIC of S. rebaudiana against 
B. subtilis and E. coli to be 500 mg/ml [29]. Earlier studies have also 
reported that the aqueous and ethanolic extract of Stevia possesses 
broad spectrum antimicrobial activity against microorganisms such as 
S. aureus, S. epidermidis, B. subtilis, and P. aeruginosa. Stevia has been 
known to possess antibacterial, antifungal, and antiviral properties [30]. 
Further, the lead fraction also exhibited strong antioxidant activity 
via free radical scavenging activity. The antioxidant activity of this 
methanolic extract (88.48%) was better than that of antioxidant activity 
reported from earlier Stevia extract (71.75% and 86.4%) [12,31]. 
Following scavenging reaction, there was a noticeable change in color 
from purple to yellow. The change in color was due to the reaction of the 
extract with the antioxidant molecule which ultimately resulted in the 
scavenging of the radical by hydrogen donation [12]. Stevia has been 
reported to have antioxidant and antidiabetic properties in diabetic 
mice [32]. Thus, the Stevia plant offers to be a promising source of 
bioactive compounds with efficient medicinal properties. To date, there 
are no reports on determination of lipase inhibitory and α-amylase 
inhibitory activity from an extract of in vitro grown Stevia plant. This 
study is the pioneering work where the lipase and α-amylase inhibitory 
activities of the methanolic extract of Stevia plant along with potential 
antioxidant and antimicrobial activities were explored.
CONCLUSION
In vitro raised novel strain of Stevia plant contains a potential 
pharmacophore which can be used as an herbal formulation for a safer 
management of obesity and related diseases. Market today needs a 
natural drug for the two most prevailing and interrelating diseases. 
Purification, structural and biochemical characterization of the 
bioactive compound in the lead extract will lead to a natural drug for 
obesity and diabetes management.
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